A post market study for monitoring of the safety of Matrine injection

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OPC-15006782

Enrollment

Unknown

Registered

2015-07-21

Start date

2015-03-01

Completion date

Unknown

Last updated

2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tumors

Interventions

Case series:Matrine injection

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: All patients using the Matrine injection.

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

Measure	Time frame
Any adverse events;	—

Countries

China

Contacts

Public ContactYou Rongli

Zhen Dong Pharmaceutical Company

wangkaihua@gxcro.com+86 18735580266

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026